Trademark Overview
On Thursday, May 23, 2024, a trademark application was filed for ISLETREGEN with the United States Patent and Trademark Office. The USPTO has given the ISLETREGEN trademark a serial number of 98566071. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 14, 2025. This trademark is owned by IsletRegen, LLC. The ISLETREGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development of drugs and medicines for the treatment of diabetes, autoimmune thyroiditis, polyneuropathy, autoimmune biliary diseases and poly autoimmunity, degenerative diseases, and other diseases requiring both cellular regenerative activity and suppression of autoimmunity; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on diabetes, autoimmune thyroiditis, polyneuropathy, autoimmune biliary diseases and poly autoimmunity, degenerative diseases and other diseases requiring both cellular regenerative activity and suppression of autoimmunity; Pharmaceutical products testing, analysis, research, and development
